Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancer
Glenn J. Hanna(Dana-Farber Cancer Institute), Cloud P. Paweletz(Massachusetts General Hospital), Pasi A. Jänne(Harvard University), Abhishek R. Mogili(Dana-Farber Cancer Institute), Umair Mahmood(Dana-Farber Cancer Institute), Julianna Supplee(Dana-Farber Cancer Institute), Robert I. Haddad(Georgetown University), Christie J. Lau(Dana-Farber Cancer Institute)
Cited by 64
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer
|New England Journal of Medicine|2013|3.4k